Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy

NCT04161053 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hepatic Encephalopathy

Interventions

DRUG: Rifaximin
DRUG: Nitazoxanide

Sponsor

Tanta University